Sai Life Sciences IPO: From price band to lot size, 10 key points about ₹3,043 crore public offer

Sai Life Sciences IPO: 10 key points

• Sai Life Sciences IPO subscription period: The bidding timeline for Sai Life Sciences IPO is December 11 to December 13.
• Sai Life Sciences IPO anchor bidding: The offer will be open for anchor investors for a day on Tuesday, December 10.
• IPO offer structure: The ₹3,042.62 crore issue is a mix of fresh issuance of shares worth up to ₹950 crore and an offer for sale (OFS) of 3.81 crore shares by a promoter and existing shareholders.
• Sai Life Sciences IPO price band: The company has set a price band of ₹522-₹549 per equity share.
• Reservation: The firm has reserved 50% of the net offer for qualified institutional investors (QIBs), 35% for retail investors, and 15% for non-institutional investors.
• Sai Life Sciences IPO lot size: A lot of Sai Life Sciences' initial share sale consists of 27 shares, taking the transaction size to ₹14,823.
• Objective: Fresh issue proceeds of ₹720 crore will be used for debt payment and the remaining for corporate general purposes.
• Book-running lead manager and registrar: IIFL Capital Services Ltd, Kotak Mahindra Capital Company Ltd, Morgan Stanley India Company, and Jefferies India are the book-running lead managers, while KFin Technologies Ltd is the IPO registrar.
• Allotment date: The basis of allotment will be finalised on December 16.
• Listing date: The company's shares are proposed to be listed on the NSE and the BSE.

Sai Life Sciences provides comprehensive services throughout the drug discovery, development, and manufacturing value chain for small molecule New Chemical Entities (NCE), catering to global pharmaceutical innovators and biotechnology firms.

During the first half of the financial year 2024-25, Sai Life Sciences posted a total income of ₹693.35 crore compared to ₹656.8 crore a year back. It reported a net profit of ₹28.01 crore in H1 FY25 against a net loss of ₹12.92 crore in the same period last year.